Prostaglandins exert a protective effect on colonic mucosa in experimentally induced colitis. This study investigated the effect of enprostil, a prostaglandin E 2 (PGE 2 ) analogue, on trinitrobenzenesulphonic acid (TNBS)-induced colitis in rats. Each rat received a rectal enema containing TNBS (30 mg), followed 24 h later by intrarectal once-daily enprostil (200 µg). Enprostil-treated and control rats were killed on day 3 (enprostil group, n = 5; control, n = 6) or day 10 (enprostil group, n = 5; control, n = 5) after TNBS treatment. The area of damaged mucosa of the colon was measured relative to the total colonic area. We also determined the macroscopic score of mucosal damage, and measured PGE 2 , 6-ketoprostaglandin F 1␣ (6-keto-PGF 1␣ ) and thromboxane B 2 (TXB 2 ) concentration in portal vein blood samples. Enprostil significantly reduced both the area of damaged mucosa (including the ulcer area) and the macroscopic score after 3 days' treatment compared with control. Similarly, enprostil significantly reduced plasma concentration of PGE 2 , 6-keto-PGF 1␣ and TXB 2 during the acute phase at day 3 of treatment compared with control, but not at day 10. These results suggest that PGE 2 enema may have therapeutic potential for treating patients with proctitis or left-sided colitis.
INTRODUCTION
The inflammatory response is modulated by several mediators, including neutrophilderived leukotriene B 4 (LTB 4 ), thromboxane B 2 (TXB 2 ) and prostaglandin E 2 (PGE 2 ). Previous studies have shown that eicosanoid concentration reflects the inflammatory activity in the gastrointestinal tract of patients with ulcerative colitis, and that the concentration of prostaglandins in the lumen correlates inversely with the ability of the gastrointestinal tract to absorb electrolytes and fluid. 1 -5 In addition, other studies have shown that there is a direct relationship between the concentration of PGE 2 , 6-keto-PGF 1α , TXB 2 and LTB 4 in the gut and the severity of disease. 6 -8 It has been established that pre-treatment with PGE 2 , 16,16-dimethyl-PGE 2 , or misoprostol (a prostaglandin E 1 [PGE 1 ] analogue) protects against the development of colitis in experimental models. 9 -13 Furthermore, a single dose of 16,16-dimethyl-PGE 2 administered 24 h after induction of experimental colitis also inhibited the inflammatory reaction in the rat model of experimental TNBS-induced colitis. 14 To our knowledge, however, there have been no reports of the therapeutic effects of daily enemas of PGE 2 .
Here, we used the PGE 2 analogue, enprostil, which has been shown previously to have a potent cytoprotective effect in the stomach as compared with pure PGE 2 . 15 -17 We investigated the effects of enemas of enprostil on colonic ulceration, mucosal injury and eicosanoid concentration in the portal vein, in rats with 2,4,6-trinitrobenzenesulphonic acid (TNBS)-induced colitis.
MATERIALS AND METHODS

MATERIALS
The stock powder of enprostil (4,5-dihydro-16phenoxy-17,18,19,20-tetranor-PGE 2 ; Lot No. E2KY-001) used in this experiment was kindly provided by Syntex Pharmaceuticals Inc. (Palo Alto, CA, USA). The powder was dissolved with propylene carbonate/saline (Lot No. E6MH-003) to a concentration of 100 µg/ml, and then stored at -80°C. Trinitrobenzenesulphonic acid was obtained from Sigma Chemical Co. (St. Louis, MO, USA).
ANIMALS
Male Sprague-Dawley rats aged 10 weeks and weighing 200 -250 g were obtained from Charles River (Kumamoto, Japan) and maintained individually in environmentally controlled rooms. Rats were fasted for 2 days before the induction of colitis, and 3.0 ml magnesium citrate (13.6%) was administered orally 24 h before the introduction of colitis. This was followed by intestinal irrigation. During the remaining period of the experiment, the rats were provided with laboratory chow and water ad lib.
The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Nagasaki University School of Medicine.
INDUCTION OF COLITIS
The rats were anesthetized by intraperitoneal injection of pentobarbitone 0.05 mg/kg and atropine sulphate 0.3 mg/kg. After insertion of a balloon catheter into the rectum to 5 cm from the anal ring, TNBS (30 mg) in 1.5 ml of ethanol (30%) was administered via a rectal enema. The balloon was clamped for 60 min while the rat was maintained in the Trendelenburg's position.
TREATMENT
Rats were divided into two groups: enprostil-treated and control. All agents were administered intrarectally, after general anesthesia, with pentobarbitone and atropine sulphate as described above. For the duration of treatment, enprostil (200 µg) et al.
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was administered once daily, commencing 24 h after the introduction of TNBS. After each enema, the catheter was clamped for 60 min. The control group received 2.0 ml propylene carbonate/saline solution through the same route and the fluid was also retained for 60 min.
TREATMENT EVALUATION
At days 3 or 10 of treatment, following ether anesthesia, blood samples were withdrawn from the portal vein, and the entire colon from the ileocaecal junction to the rectum was removed immediately after death.
DETERMINATION OF THE ULCER AREA.
The removed colon was incised from the site of adherence to the mesentery, gently spread out with the mucosal surface facing upwards and then placed on an acrylic plate. After cooling to -20°C, saline was poured gently on the plate until the tissue was completely immersed, photographs were taken, and the total area of the colon as well as the area of damaged mucosa were determined using a software package (WACOM WT-4400SE: WIZE Computer, Nagasaki, Japan).
MACROSCOPIC SCORING. The macroscopic scores were calculated based on the presence or absence of an ulcer and the degree of damage to the colonic mucosa, using the criteria of Wallace and Keenan. 18 DETERMINATION OF EICOSANOID CON-CENTRATIONS. Plasma samples derived from the blood taken from the portal vein were sent to SRL, Inc. (Tokyo, Japan) for determination of PGE 2 , 6-keto-PGF 1α and TXB 2 concentration by radioimmunoassay. 19
STATISTICAL ANALYSIS
Data were expressed as the mean values ± SE for each group. Differences between groups were examined for statistical significance using the Mann-Whitney U test. A P-value of less than 0.05 indicated statistical significance.
RESULTS
EFFECTS OF ENPROSTIL ON COLONIC DAMAGED AREA
Rats treated with TNBS showed mucosal damage consisting of mucosal haemorrhage, oedema and deep ulceration. The ratio of the damaged area relative to total area of excised colon at day 3 in the enprostil group (1.60 ± 0.85%) was significantly lower than in the control group (9.36 ± 3.81%, P < 0.05).
The corresponding values at day 10 showed no significant difference between the two groups ( Fig. 1A) .
EFFECTS OF ENPROSTIL ON MACROSCOPIC SCORE
The average macroscopic score at day 3 in the enprostil group (2.33 ± 0.86) was significantly lower than in the control group (5.57 ± 1.62, P < 0.01). However, no statistically significant difference in macroscopic scores was seen between the two groups at day 10 ( Fig. 1B) .
EFFECTS OF ENPROSTIL ON EICOSANOID CONCENTRATIONS
The plasma concentration of PGE 2 at day 3 in the enprostil-treated group (1.0 ± 0.6 ng/ml) was significantly lower than in the control group (3.3 ± 0.6 ng/ml, P < 0.05; Fig. 2A ). Plasma 6-keto-PGF 1α concentration at day 3 in the enprostil group (64 ± 18.3 pg/ml) was also significantly lower than in the control group (557 ± 165 pg/ml, P < 0.01; Fig. 2B) . Similarly, at day 3, TXB 2 concentration in the enprostil group (16 ± 7.7 pg/ml) was significantly lower than in the control group (144 ± 67.9 pg/ml, P < 0.05; Fig. 2C ). However, at day 10, plasma concentrations et al.
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of PGE 2 , 6-keto-PGF 1α and TXB 2 were not significantly different between the two groups (Figs 2A, B and C).
DISCUSSION
In this study, colitis was induced effectively by administration of TNBS in rats. Enprostil enema significantly reduced colonic ulceration, mucosal injury and portal venous concentration of PGE 2 , 6-keto-PGF 1α and TXB 2 in these rats after 3 days of treatment as compared with control. Reduced colonic ulceration, mucosal injury and PGE 2 , 6-keto-PGF 1α and TXB 2 concentrations were also observed at day 10 in the enprostiltreated group as compared with the control group although the difference between the two groups failed to reach statistical significance. PGE 2 is known to exhibit a range of antiinflammatory effects, such as inhibition of the release of tumour necrotic factor-α (TNF-α) from macrophages, 20 production of LTB 4 by neutrophils, 21 migration of leukocytes and phagocytes, 15 and wound repair. 22 Many investigators have reported high concentration of PGE 2 in the blood and gut, both in patients with ulcerative colitis and in animal models of experimental colitis. 18, 23, 24 The rise in PGE 2 concentration in the gut and blood induced by inflammation seems to be the result of a bioprophylactic mechanism. Raab et al. 25 reported that increased PGE 2 production found in the inflamed mucosa in active ulcerative colitis may be caused by activated eosinophils and macrophages. In this regard, Cohan et al. 26 and Hu et al. 27 proposed that PGE 2 is released from mast cells and macrophages. Others have reported the disparate actions of 16,16-dimethyl-PGE 2 on the inhibition of the passive cutaneous anaphylactic reaction, macrophage procoagulant-inducing factor, interleukin-2 
Mean ± SE effect of 3 and 10 days' treatment with enprostil on (A) ratio of colonic damaged area relative to total colonic area and (B) macroscopic scores for inflammation in rats treated
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(IL-2) and B-cell activation, 28 and the inhibitory action of PGE 2 inhibition on B-cell activation. 29 In TNBS-induced colitis, the concentration of PGE 2 and 6-keto-PGF 1α in the plasma are high during the acute phase while TXB 2 concentration is high during the chronic phase. Further, prednisolone and 5-aminosalicylic acid inhibited the levels of these eicosanoids predominantly during the chronic phase. 7 In addition, administration of PGE 2 may inhibit 6-keto-PGF 1α and TXB 2 , but not PGE 2 . 30 However, to our knowledge, there have been no reports of the effects of daily enemas with PGE 2 .
We observed that enprostil significantly inhibited the area of mucosal ulceration or damage and eicosanoid concentration, including PGE 2 concentration in the portal vein, during the acute phase rather than the chronic phase. As mentioned above, this suggests that enprostil may exert a stimulatory effect on healing not only by its cytoprotective effect but also by increasing mucosal blood flow. We postulate that inhibition of PGE 2 levels in the portal vein following the use of enprostil could contain that of endogenous PGE 2 , resulting from its potent pharmacological effect. Similar effects have also been observed with prostaglandin E 1 (PGE 1 ). Torsher et al. 31 showed that, in rats with TNBS-induced colitis, daily treatment with misoprostol (a long-acting PGE 1 ) caused a reduction in the area of ulceration and an improvement in the ability of the gastrointestinal tract to absorb electrolytes and water. Using the same rat model, Terzioglu et al. 32 reported the beneficial effect of PGE 1 in reducing the severity of colonic inflammation.
Whether or not prostaglandin analogues can be used therapeutically in human inflammatory bowel disease remains to be determined. In a clinical trial conducted by Goldin and Rachmilewitz, 33 patients with inflammatory bowel disease were treated orally with 15,15′ dimethyl-PGE 2 but no clinical benefit was established. Oral administration of prostaglandins, including dimethyl-PGE 2 , increases chloride secretion by small intestinal mucosa, leading to diarrhoea. Separating these effects from the clinical manifestations of inflammatory bowel disease is difficult. There are, however, prostaglandin analogues that do not increase intestinal chloride secretion. Increased PGE 2 concentration induced by inflammation suggests that this prostaglandin might act as an accelerator of healing rather than as an inflammatory factor. 34 The anti-inflammatory effects observed in this study suggest that enprostil enema may prove an effective therapy for ulcerative colitis, in addition to the established therapeutic agents for colitis, such as prednisolone and 5-aminosalicylic acid. Further animal and human studies will be needed to investigate this more fully. et al.
Endovascular Embolization of Unruptured Vertebral Dissection et al.
Endovascular Embolization of Unruptured Vertebral Dissection
